Synthego Corporation Revenue and Competitors



Total Funding



Estimated Revenue & Valuation

  • Synthego Corporation's estimated annual revenue is currently $80.7M per year.(i)
  • Synthego Corporation received $110.0M in venture funding in October 2018.
  • Synthego Corporation's estimated revenue per employee is $217,000
  • Synthego Corporation's total funding is $459.7M.

Employee Data

  • Synthego Corporation has 372 Employees.(i)
  • Synthego Corporation grew their employee count by -38% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
Add Company

Founded by former SpaceX engineers, Synthego is a leading provider of genome engineering solutions. The company's flagship product, CRISPRevolution, is a portfolio of synthetic RNA designed for CRISPR genome editing and research. Synthego's vision is to bring precision and automation to genome engineering, enabling rapid and cost-effective research with consistent results for every scientist. Headquartered in Silicon Valley, California, Synthego customers include leading institutions in 31 countries around the world, and 9 of the top 10 global biology universities.

keywords:saas, Biotechnology,Hardware,Healthcare,Pharmaceuticals


Total Funding


Number of Employees


Revenue (est)


Employee Growth %





Synthego Corporation News

2022-04-17 - Synthetic Biology Market Size And Forecast | Cyrus Biotechnology ...

(U.S.), Synthego Corporation (U.S.) among others. The report provides a good overview of the key macroeconomic factors that have a significant...

2022-04-13 - Europe CRISPR Gene Editing Market to 2031 - Featuring Abcam ...

Synthego Corporation; System Biosciences LLC; Takara Bio, Inc. Thermo Fisher Scientific, Inc. ToolGen, Inc. For more information about this...

2022-02-22 - Synthego Raises $200 Million to Accelerate the Field of CRISPR ...

Synthego was founded to revolutionize genome engineering technology, helping translate genomics into the clinic and ultimately making engineered...

2020-08-27 - Synthego Raises $100M in Series D Funding

Synthego, a Redwood City, Calif.-based genome engineering company, raised $100m in Series D financing. The round was led by new investor Wellington Management, co-led by RA Capital Management and 8VC. Additional investors included Founders Fund, Menlo Ventures, and Intel Capital. This new round ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding

Synthego Corporation Funding

DateAmountRoundLead InvestorsReference
2017-10-23$UndisclosedUndisclosedIntel CapitalArticle
2018-10-24$110.0MCFounders FundArticle